Tag Archives: Pfizer

Why Is the FDA Hiding the Pfizer Vaccine Data?

Despite the FDA’s claim that it is committed to transparency, especially for COVID-19 emergency use authorizations (EUAs),1 the agency first requested 55 years to release the data supporting the approval of Comirnaty after a Freedom of Information Act (FOIA) request was filed,2 and then asked for an extra 20 years to fully comply.3 Pfizer has… Read More »

Pfizer to Seek Approval for Booster COVID Shot, But U.S. Agencies Balk at Timing

By Ernie Mundell and Robin Foster HealthDay Reporters FRIDAY, July 9, 2021 — Pfizer and its partner BioNTech announced Thursday they would seek approval for a booster COVID-19 shot and begin studies on a reformulated vaccine that targets the highly contagious Delta variant. “We continue to believe that it is likely, based on the totality… Read More »

Pfizer vaccine efficacy drops in Israel as delta variant spreads

Pfizer vaccine efficacy drops in Israel amid rapid spread of Indian variant… but No10 insists two doses are still highly effective Health Ministry figures showed the jab blocked infections in 64 per cent of cases But before the Indian variant emerged it stopped disease in 94 per cent of cases Israeli officials said symptoms were… Read More »

Some 62,000 register for Pfizer in NSW

More than 62,000 people in NSW aged between 40 and 49 have joined a wait list to be jabbed with the Pfizer COVID-19 vaccine in less than 24 hours. Premier Gladys Berejiklian on Monday announced around a million people in that age bracket could get a Pfizer COVID-19 jab at the new purpose-built vaccination hub… Read More »

Pfizer CEO predicts coronavirus oral antiviral pill ready ‘by end of year’

Albert Bourla, chairman and CEO of Pfizer, said Tuesday he hopes the company’s coronavirus oral antiviral therapeutic in early-stage trials will be ready by the end of the year. “…If all goes well and we implement the same speed that we did so far and we are and if regulators also do the same and they are,… Read More »

Pfizer Japan drawn into valsartan recall after finding API from Mylan is tainted

The global recall of valsartan has now extended to Pfizer and to Japan, via Mylan and India. According to a translated copy of its announcement, Pfizer’s Tokyo-based Japanese subsidiary said it is recalling from the country five lots of its blood pressure combo drug Amubaro because its API contains impurities that are probable carcinogens. The recall began… Read More »